Sally Pipes: Bernie Sanders Offers Wrong Solution to Cut Drug Prices
Featured in Fox News | Sally C. Pipes
July 28, 2019
Sanders is right about one thing. Americans pay too much at the pharmacy counter. But drug companies are hardly the culprits. If he really wanted to help patients, Sanders would attack the root of the problem – America’s opaque and convoluted drug pricing system.
Americans with Type 1 diabetes have seen their drug costs skyrocket in recent years. Between 2012 and 2016, annual spending on insulin for these patients grew from $2,864 to $5,705.
Read more . . .
|
|
Food Labeling Follies
Henry I. Miller, M.S., M.D.
July 29, 2019
California’s Office of Administrative Law (OAL) recently made it official: Your morning cup of coffee won’t give you cancer. Next week’s newsflash probably will be, swallowing an orange seed doesn’t cause a tree to grow in your stomach.
Read more . . .
|
|
Wayne Winegarden in Forbes: Inflation Caps Are Price Controls By Another Name
Forbes | Wayne Winegarden
July 26, 2019
Instead of embracing a new “big government” fix to the health care system, Congress should start addressing the underlying flaws leading to the undesired outcomes. These include enabling greater transparency in the pricing of drugs, improved efficiency in the supply chain, and broader payment reforms.
Read more . . .
|
|
Opioids: Bad Science, Bad Policy, Bad Outcomes
Issues and Insights | Henry I. Miller, M.S., M.D. and Josh Bloom
July 26, 2019
The problem is quite real, but legislators and regulators are making incorrect assumptions and adopting flawed strategies. And then, there are some flawed clinical studies and statements by the U.S. surgeon general that conspire to create misunderstanding of the landscape . . .
Read more . . .
|
|
|
|
